SEC Form 4 · accession 0001562180-18-002940
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Federici
Officer — Sr. VP & CFO
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 10:01 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2018 | M | 75,662 | $21.34 | A | 270,681 | D | |
| Common StockF1 | Jun 8, 2018 | S | 42,869 | $96.09 | D | 227,812 | D | |
| Common Stock | holding | — | — | — | 1,046 | I | By 401(k) Plan | |
| Common Stock | holding | — | — | — | 17,061 | I | By Nonqualified Deferred Comp Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $21.34 | Jun 8, 2018 | M | 75,662 | D | — | Mar 22, 2020 | Common Stock | 75,662 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $95.76 USD to $96.34 USD; the price reported above reflects the weighted average sale price.
- F2This award vests in 4 equal annual installments beginning on 3/22/2011.